Home

Matters brought to the attention of the Economic and Social Council . . . . . . . . . . . . . . . . 8 Resolution 58/1 Improving the governance and financial situation of the United Nations Office on Drugs and Crime: recommendations of the standing open-ended intergovernmental working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Resolution 58/2 Supporting the availability, accessibility and diversity of scientific evidence-based treatment and care for children and young people with substance use disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Resolution 58/3 Promoting the protection of children and young people, with particular reference to the illicit sale and purchase of internationally or nationally controlled substances and of new psychoactive substances via the Internet . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Resolution 58/4 Promoting the implementation of the United Nations Guiding Principles on Alternative Development . . . . . . . . . . . . . . . . . . . . . . . 17 Resolution 58/5 Supporting the collaboration of public health and justice authorities in pursuing alternative measures to conviction or punishment for appropriate drug-related offences of a minor nature . . . . . . . . . . . . . 21 Resolution 58/6 Strengthening international cooperation in preventing and combating illicit financial flows linked to drug trafficking, from the anti-money-laundering perspective . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 E/2015/28 E/CN.7/2015/15 iv V.15-02178 Resolution 58/7 Strengthening cooperation with the scientific community, including academia, and promoting scientific research in drug demand and supply reduction policies in order to find effective solutions to various aspects of the world drug problem . . . . . . . . . . . . . . . . . . . . . 28 Resolution 58/8 Special session of the General Assembly on the world drug problem to be held in 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 Resolution 58/9 Promoting the role of drug analysis laboratories worldwide and reaffirming the importance of the quality of the analysis and results of such laboratories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 Resolution 58/10 Promoting the use of the international electronic import and export authorization system for licit international trade in narcotic drugs and psychotropic substances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Resolution 58/11 Promoting international cooperation in responding to new psychoactive substances and amphetamine-type stimulants, including methamphetamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Decision 58/1 Inclusion of mephedrone (4-methylmethcathinone) in Schedule II of the Convention on Psychotropic Substances of 1971 . . . . . . . . . . . . 42 Decision 58/2 Review of ketamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42 Decision 58/3 Inclusion of AH-7921 in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol . . . . . . . . 43 Decision 58/4 Review of gamma-butyrolactone (GBL) . . . . . . . . . . . . . . . . . . . . . . . 43 Decision 58/5 Review of 1,4-butanediol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 Decision 58/6 Inclusion of 25B-NBOMe (2C-B-NBOMe) in Schedule I of the Convention on Psychotropic Substances of 1971 . . . . . . . . . . . . . . . . 43 Decision 58/7 Inclusion of 25C-NBOMe (2C-C-NBOMe) in Schedule I of the Convention on Psychotropic Substances of 1971 . . . . . . . . . . . . . . . . 44 Decision 58/8 Inclusion of 25I-NBOMe (2C-I-NBOMe) in Schedule I of the Convention on Psychotropic Substances of 1971 . . . . . . . . . . . . . . . . 44 Decision 58/9 Inclusion of N-benzylpiperazine (BZP) in Schedule II of the Convention on Psychotropic Substances of 1971 . . . . . . . . . . . . . . . . 44 Decision 58/10 Inclusion of JWH-018 in Schedule II of the Convention on Psychotropic Substances of 1971 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 Decision 58/11 Inclusion of AM-2201 in Schedule II of the Convention on Psychotropic Substances of 1971 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45 Decision 58/12 Inclusion of 3,4-methylenedioxypyrovalerone (MDPV) in Schedule II of the Convention on Psychotropic Substances of 1971 45 Decision 58/13 Inclusion of methylone (beta-keto-MDMA) in Schedule II of the Convention on Psychotropic Substances of 1971 . . . . . . . . . . . . . . . . 45 V.15-02178 v E/2015/28 E/CN.7/2015/15 Decision 58/14 Provisional agenda for the special segment to be held during the reconvened fifty-eighth session of the Commission on Narcotic Drugs, on preparations for the special session of the General Assembly on the world drug problem to be held in 2016 . . . . . . . . . 45 Decision 58/15 Preliminary provisional agenda for the special segment to be held during the fifty-ninth session of the Commission on Narcotic Drugs, on preparations for the special session of the General Assembly on the world drug problem to be held in 2016 . . . . . . . . . . . . . . . . . . . . . 46 II. (...) Furthermore, the Commission decided to include mephedrone (4-methylmethcathinone), N-benzylpiperazine (BZP), JWH-018, AM-2201, 3,4-methylenedioxypyrovalerone (MDPV) and methylone (beta-keto-MDMA) in Schedule II of the 1971 Convention.

· 26 June 1950, . the Representative AssemblY ciass:liied -~ l.aDd in question as · part ot the Territory's pr;lvate clcme.in,' awarded c:aupensation of 14 m:Ullon francs to the Bonadouma cGmnunity and declarei w1thdra~ .fran the Territory's private domain a parcel ~ 11 hectare~ in respect at which it allowed individUal rights t~ members ~- the Bonat~keto f'am1.4r, which is part of' the , J3onedouma· ·c~ity. . · ' . · : ·. ' · .

The stereoisomers, unless specifically excepted, of substances in this Schedule, whenever the existence of such stereoisomers is possible within the specific chemical designation.     3  Schedules of the Convention on Psychotropic Substances of 1971, as at 13 November 2016   List of substances in Schedule II International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name α-Pyrrolidinovalero phenone, α-PVP 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one Amfetamine Amphetamine (±)-α-Methylphenethylamine Amineptine 7-[(10,11-Dihydro-5H-dibenzo[a,d] cyclohepten-5-yl)amino]heptanoic acid N-benzylpiperazine, BZP 1-Benzylpiperazine 2C-B 4-Bromo-2,5-dimethoxyphenethylamine Dexamfetamine Dexamphetamine (+)-α-Methylphenethylamine Dronabinol* delta-9-Tetrahydro- cannabinol and its stereochemical variants (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9- trimethyl-3-pentyl-6H-dibenzo[b,d] pyran- 1-ol Fenetylline 7-[2-[(α-Methylphenethyl)amino]ethyl] theophylline GHB γ-Hydroxybutyric acid Levamfetamine Levamphetamine (-)-(R)-α-Methylphenethylamine Levomethamphetamine (-)-N,α-Dimethylphenethylamine Mecloqualone 3-(o-Chlorophenyl)-2-methyl-4(3H) Quinazolinone Mephedrone,4- methylmethcathinone (RS)-2-(methylamino)-1-(4-methylphenyl) propan-1-one Metamfetamine Methamphetamine (+)-(S)-N,α-Dimethylphenethylamine Metamfetamine racemate Methamphetamine racemate (±)-N,α-Dimethylphenethylamine Methaqualone 2-Methyl-3-o-tolyl-4(3H)quinazolinone Methoxetamine, MXE 2-(ethylamino)-2-(3-methoxyphenyl) cyclohexanone 3,4-Methylenedioxypyro- valerone, MDPV (RS)-1-(benzo[d][1,3]dioxol-5-yl)-2- (pyrrolidin-1-yl)pentan-1-one Methylone, beta-keto- MDMA (RS)-2-methylamino-1-(3,4- methylenedioxyphenyl)propan-1-one Methylphenidate Methyl α-phenyl-2-piperidine acetate JWH-018 Naphthalen-1-yl(1-pentyl-1H-indol-3-yl) methanone AM-2201 1-(5-fluoropentyl)-1H-indol-3-yl]- (naphthalen-1-yl)methanone para-Methyl-4- methylaminorex, 4,4’-DMAR 4-methyl-5-(4-methylphenyl)-4,5-dihydro- 1,3-oxazol-2-amine Phencyclidine PCP 1-(1-Phenylcyclohexyl)piperidine Phenmetrazine 3-Methyl-2-phenylmorpholine 4  The International Drug Control Conventions International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name Secobarbital 5-Allyl-5-(1-methylbutyl)barbituric acid Zipeprol α-(α-Methoxybenzyl)-4-(β- methoxyphenethyl)-1-piperazineethanol   The salts of the substances listed in this Schedule whenever the existence of such salts is possible

The stereoisomers, unless specifically excepted, of substances in this Schedule, whenever the existence of such stereoisomers is possible within the specific chemical designation. 3 Schedules of the Convention on Psychotropic Substances of 1971, as at 18 October 2017 List of substances in Schedule II International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name α-Pyrrolidinovalero phenone, α-PVP 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one Amfetamine Amphetamine (±)-α-Methylphenethylamine Amineptine 7-[(10,11-Dihydro-5H-dibenzo[a,d] cyclohepten-5-yl)amino]heptanoic acid N-benzylpiperazine, BZP 1-Benzylpiperazine 2C-B 4-Bromo-2,5-dimethoxyphenethylamine Dexamfetamine Dexamphetamine (+)-α-Methylphenethylamine Dronabinol* delta-9-Tetrahydro- cannabinol and its stereochemical variants (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9- trimethyl-3-pentyl-6H-dibenzo[b,d] pyran- 1-ol Ethylone 1-(2H-1,3-benzodioxol-5-yl)-2- (ethylamino)propan-1-one Ethylphenidate ethyl phenyl(piperidin-2-yl)acetate 5F-APINACA (5F-AKB-48) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H- indazole-3-carboxamide Fenetylline 7-[2-[(α-Methylphenethyl)amino]ethyl] theophylline GHB γ-Hydroxybutyric acid Levamfetamine Levamphetamine (-)-(R)-α-Methylphenethylamine Levomethamphetamine (-)-N,α-Dimethylphenethylamine 4-Methylethcathinone (4-MEC) 2-(ethylamino)-1-(4-methylphenyl) propan- 1-one Mecloqualone 3-(o-Chlorophenyl)-2-methyl-4(3H) Quinazolinone Mephedrone,4- methylmethcathinone (RS)-2-(methylamino)-1-(4-methylphenyl) propan-1-one Metamfetamine Methamphetamine (+)-(S)-N,α-Dimethylphenethylamine Metamfetamine racemate Methamphetamine racemate (±)-N,α-Dimethylphenethylamine Methaqualone 2-Methyl-3-o-tolyl-4(3H)quinazolinone Methoxetamine, MXE 2-(ethylamino)-2-(3-methoxyphenyl) cyclohexanone 3,4-Methylenedioxypyro- valerone, MDPV (RS)-1-(benzo[d][1,3]dioxol-5-yl)-2- (pyrrolidin-1-yl)pentan-1-one Methylone, beta-keto- MDMA (RS)-2-methylamino-1-(3,4- methylenedioxyphenyl)propan-1-one Methylphenidate Methyl α-phenyl-2-piperidine acetate JWH-018 Naphthalen-1-yl(1-pentyl-1H-indol-3-yl) methanone 4 The International Drug Control Conventions International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name AM-2201 1-(5-fluoropentyl)-1H-indol-3-yl]- (naphthalen-1-yl)methanone para-Methyl-4- methylaminorex, 4,4’-DMAR 4-methyl-5-(4-methylphenyl)-4,5-dihydro- 1,3-oxazol-2-amine MDMB-CHMICA methyl N-{[1-(cyclohexylmethyl)-1H-indol- 3-yl]carbonyl}-3-methyl-L-valinate Methiopropamine (MPA) N-methyl-1-(thiophen-2-yl)propan-2-amine Pentedrone 2-(methylamino)-1-phenylpentan-1-one Phencyclidine PCP 1-(1-Phenylcyclohexyl)piperidine Phenmetrazine 3-Methyl-2-phenylmorpholine Secobarbital 5-Allyl-5-(1-methylbutyl)barbituric acid XLR-11 [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl) methanone Zipeprol α-(α-Methoxybenzyl)-4-(β- methoxyphenethyl)-1-piperazineethanol The salts of the substances listed in this Schedule whenever the existence of such salts is possible

Xuntuir Labtam hvdopmMt NB. Keto Starr #mm11 Wnncratic Pcq~lc's Republic Mr.tiInHo o f Km-m Mr. .!

.: 032 (NBI/2016) Date: 25 February 2016 Original: English Before: Judge Vinod Boolell Registry: Nairobi Registrar: Abena Kwakye-Berko KETO v. SECRETARY-GENERAL OF THE UNITED NATIONS ORDER STRIKING OUT A PREMATURE APPLICATION Counsel for the Applicant: Abbe Jolles Counsel for the Respondent: ALS/OHRM Case No. (...) Pursuant to article 19 of the UNDT Rules of Procedure, the Tribunal strikes out the matter of Keto v. The Secretary-General of the United Nations, Case No.

The stereoisomers, unless specifically excepted, of substances in this Schedule, whenever the existence of such stereoisomers is possible within the specific chemical designation. 5 T h e In te rn a tio n a l D ru g C o n tro l C o n ven tio n s - S ch e d u les o f th e C o n ve n tio n o n P syc h o tro p ic S u b sta n ce s o f 1 9 7 1 , a s a t 1 9 N o v em b e r 2 0 1 9 S ch ed u le II List of substances in Schedule II International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name α-Pyrrolidinovalerophenone, α-PVP 1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one AB-CHMINACA N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide AB-PINACA N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide ADB-CHMINACA (MAB-CHMINACA) N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ADB-FUBINACA N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide AM-2201 1-(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone Amfetamine Amphetamine (±)-α-Methylphenethylamine Amineptine 7-[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid N-Benzylpiperazine, BZP 1-Benzylpiperazine 2C-B 4-Bromo-2,5-dimethoxyphenethylamine CUMYL-4CN-BINACA 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide Dexamfetamine Dexamphetamine (+)-α-Methylphenethylamine Dronabinol* delta-9-Tetrahydro-cannabinol and its stereochemical variants (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d] pyran-1-ol Ethylone 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one Ethylphenidate Ethyl phenyl(piperidin-2-yl)acetate 4-Fluoroamphetamine (4-FA) 1-(4-Fluorophenyl)propan-2-amine 5F-APINACA (5F-AKB-48) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide 5F-MDMB-PINACA (5F-ADB), Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate Fenetylline 7-[2-[(α-Methylphenethyl)amino]ethyl]theophylline 5F-PB-22 Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate GHB γ-Hydroxybutyric acid JWH-018 Naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone Levamfetamine Levamphetamine (-)-(R)-α-Methylphenethylamine Levomethamphetamine (-)-N,α-Dimethylphenethylamine MDMB-CHMICA Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate Mecloqualone 3-(o-Chlorophenyl)-2-methyl-4(3H)Quinazolinone Mephedrone, 4-methylmethcathinone (RS)-2-(Methylamino)-1-(4-methylphenyl)propan-1-one 6 T h e In te rn a tio n a l D ru g C o n tro l C o n ven tio n s - S ch e d u les o f th e C o n ve n tio n o n P syc h o tro p ic S u b sta n ce s o f 1 9 7 1 , a s a t 1 9 N o v em b e r 2 0 1 9 S ch ed u le II International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name Metamfetamine Methamphetamine (+)-(S)-N,α-Dimethylphenethylamine Metamfetamine racemate Methamphetamine racemate (±)-N,α-Dimethylphenethylamine Methaqualone 2-Methyl-3-o-tolyl-4(3H)quinazolinone Methiopropamine (MPA) N-Methyl-1-(thiophen-2-yl)propan-2-amine Methoxetamine, MXE 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone 3,4-Methylenedioxypyro-valerone, MDPV (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one 4-Methylethcathinone (4-MEC) 2-(Ethylamino)-1-(4-methylphenyl) propan-1-one Methylone, beta-keto-MDMA (RS)-2-Methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one Methylphenidate Methyl α-phenyl-2-piperidine acetate N-Ethylnorpentylone (ephylone) 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one para-Methyl-4-methylaminorex, 4,4’-DMAR 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine Pentedrone 2-(Methylamino)-1-phenylpentan-1-one Phencyclidine PCP 1-(1-Phenylcyclohexyl)piperidine Phenmetrazine 3-Methyl-2-phenylmorpholine Secobarbital 5-Allyl-5-(1-methylbutyl)barbituric acid UR-144 1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone XLR-11 [1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone Zipeprol α-(α-Methoxybenzyl)-4-(β-methoxyphenethyl)-1-piperazineethanol The salts of the substances listed in this Schedule whenever the existence of such salts is possible

.: 014 (NBI/2016) Date: 2 February 2016 Original: English Before: Judge Vinod Boolell Registry: Nairobi Registrar: Abena Kwakye-Berko KETO v. SECRETARY-GENERAL OF THE UNITED NATIONS ORDER ON CASE MANAGEMENT Counsel for the Applicant: Abbe Jolles Counsel for the Respondent: ALS/OHRM Case No.

The stereoisomers, unless specifically excepted, of substances in this Schedule, whenever the existence of such stereoisomers is possible within the specific chemical designation. 5 T h e In te rn a tio n a l D ru g C o n tro l C o n ven tio n s - S ch e d u les o f th e C o n ve n tio n o n P syc h o tro p ic S u b sta n ce s o f 1 9 7 1 , a s a t 3 N o ve m b er 2 0 2 0 S ch ed u le II List of substances in Schedule II International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name α-Pyrrolidinovalerophenone, α-PVP 1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one AB-CHMINACA N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide AB-FUBINACA N-[1-Amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide AB-PINACA N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide ADB-CHMINACA (MAB-CHMINACA) N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ADB-FUBINACA N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide alpha-PHP 1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one AM-2201 1-(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone Amfetamine Amphetamine (±)-α-Methylphenethylamine Amineptine 7-[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid N-Benzylpiperazine, BZP 1-Benzylpiperazine 2C-B 4-Bromo-2,5-dimethoxyphenethylamine 4-CMC (4-chloromethcathinone, clephedrone) 1-(4-Chlorophenyl)-2-(methylamino)propan-1-one CUMYL-4CN-BINACA 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide Dexamfetamine Dexamphetamine (+)-α-Methylphenethylamine Dronabinol* delta-9-Tetrahydro-cannabinol and its stereochemical variants (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d] pyran-1-ol N-Ethylhexedrone 2-(Ethylamino)-1-phenylhexan-1-one N-Ethylnorpentylone (ephylone) 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one Ethylone 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one Ethylphenidate Ethyl phenyl(piperidin-2-yl)acetate 4-Fluoroamphetamine (4-FA) 1-(4-Fluorophenyl)propan-2-amine 4F-MDMB-BINACA Methyl 2-{[1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate 5F-AMB-PINACA (5F-AMB, 5F-MMB-PINACA) Methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate 5F-APINACA (5F-AKB-48) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide 5F-MDMB-PICA (5F-MDMB-2201) Methyl 2-{[1-(5-fluoropentyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate 5F-MDMB-PINACA (5F-ADB), Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate Fenetylline 7-[2-[(α-Methylphenethyl)amino]ethyl]theophylline 6 T h e In te rn a tio n a l D ru g C o n tro l C o n ven tio n s - S ch e d u les o f th e C o n ve n tio n o n P syc h o tro p ic S u b sta n ce s o f 1 9 7 1 , a s a t 3 N o ve m b er 2 0 2 0 S ch ed u le II International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name 5F-PB-22 Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate GHB γ-Hydroxybutyric acid JWH-018 Naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone Levamfetamine Levamphetamine (-)-(R)-α-Methylphenethylamine Levomethamphetamine (-)-N,α-Dimethylphenethylamine MDMB-CHMICA Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate Mecloqualone 3-(o-Chlorophenyl)-2-methyl-4(3H)Quinazolinone Mephedrone, 4-methylmethcathinone (RS)-2-(Methylamino)-1-(4-methylphenyl)propan-1-one Metamfetamine Methamphetamine (+)-(S)-N,α-Dimethylphenethylamine Metamfetamine racemate Methamphetamine racemate (±)-N,α-Dimethylphenethylamine Methaqualone 2-Methyl-3-o-tolyl-4(3H)quinazolinone Methiopropamine (MPA) N-Methyl-1-(thiophen-2-yl)propan-2-amine Methoxetamine, MXE 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone 3,4-Methylenedioxypyro-valerone, MDPV (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one 4-Methylethcathinone (4-MEC) 2-(Ethylamino)-1-(4-methylphenyl) propan-1-one Methylone, beta-keto-MDMA (RS)-2-Methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one Methylphenidate Methyl α-phenyl-2-piperidine acetate para-Methyl-4-methylaminorex, 4,4’-DMAR 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine Pentedrone 2-(Methylamino)-1-phenylpentan-1-one Phencyclidine PCP 1-(1-Phenylcyclohexyl)piperidine Phenmetrazine 3-Methyl-2-phenylmorpholine Secobarbital 5-Allyl-5-(1-methylbutyl)barbituric acid UR-144 1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone XLR-11 [1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone Zipeprol α-(α-Methoxybenzyl)-4-(β-methoxyphenethyl)-1-piperazineethanol The salts of the substances listed in this Schedule whenever the existence of such salts is possible